英文名稱 |
中文名稱 |
CAS號 |
操作 |
Losartan EP Impurity K |
氯沙坦甲醛 |
114798-36-6 |
詳細
|
Imatinib Impurity 12 |
4-氯甲基-N-[4-甲基-3-[[4-(吡啶-3-基)嘧啶-2-基]氨基]苯基]苯甲酰胺 |
404844-11-7 |
詳細
|
5-Vinylbenzo[d][1,3]dioxole |
5-乙烯基苯并[D][1,3]二氧雜環(huán)戊烯 |
7315-32-4 |
詳細
|
Losartan EP Impurity C |
洛沙坦雜質(zhì)C |
114799-13-2 |
詳細
|
Levofloxacin EP Impurity G HCl |
左氧氟沙星相關(guān)物質(zhì)E |
1346603-62-0 |
詳細
|
Hydroxychloroquine O-Acetate |
羥氯喹雜質(zhì)7 |
47493-14-1 |
詳細
|
5-Chloro-6-(1-piperidinyl)-2,4-pyrimidinediamine |
5-Chloro-6-(1-piperidinyl)-2,4-pyrimidinediamine |
1784008-01-0 |
詳細
|
Diethyl (2-Oxo-2-phenylethyl)phosphonate |
(2-氧代-2-苯乙基)膦酸二乙酯 |
3453-00-7 |
詳細
|
Benzo[k]fluoranthene |
苯并[k]熒蒽 |
207-08-9 |
詳細
|
N-Fmoc-1-amino-2-methyl-2-propanol |
|
1466611-97-1 |
詳細
|
Isothipendyl HCl |
鹽酸異西噴他 |
1225-60-1 |
詳細
|
Levosimendan Impurity 6 |
左西孟旦雜質(zhì) |
220246-81-1 |
詳細
|
Isopropyl2-bromopropanoate |
2-溴丙酸異丙酯 |
7401-84-5 |
詳細
|
2,4-Diamino-5,6-dichloropyrimidine |
5,6-dichloropyrimidine-2,4-diamine |
89033-89-6 |
詳細
|
DL-Carnitine |
DL-肉堿 |
406-76-8 |
詳細
|
Lurasidone Opened Imide |
魯拉西酮雜質(zhì)24 |
1644295-07-7 |
詳細
|
Ibrutinib Dimer Impurity |
依魯替尼雜質(zhì)9 |
2031255-23-7 |
詳細
|
Methionine EP Impurity D |
蛋氨酸EP雜質(zhì)D |
1879009-96-7 |
詳細
|
Acetyl Methionine Sulfone(R/S mixture) |
|
169168-64-3 |
詳細
|
5,6-trans-Latanoprost |
反式拉坦前列素 |
913258-34-1 |
詳細
|
Levomedetomidine |
LEVOMEDETOMIDINE |
119717-21-4 |
詳細
|
Lamotrigine EP Impurity G |
3,5-二氨基-6-(2,4-二氯苯基)-1,2,4-三嗪 |
38943-76-9 |
詳細
|
Lidocaine EP Impurity J HCl |
2-(二乙氨基)-N-(2,5-二甲基苯基)乙酰胺鹽酸鹽 |
1012864-23-1 |
詳細
|
Linagliptin Methyl Dimer |
LINAGLIPTIN METHYLDIMER |
1418133-47-7 |
詳細
|
2-Bromo-3-fluoro-4-iodo-pyridine |
2-溴-3-氟-4-碘吡啶 |
1804910-90-4 |
詳細
|
Cetirizine EP Impurity D |
西替利嗪雜質(zhì)D |
346451-15-8 |
詳細
|
Methylprednisolone Aceponate |
醋丙甲潑尼龍 |
86401-95-8 |
詳細
|
Hydrocortisone Valerate |
氫化可的松-17-戊酸酯 |
57524-89-7 |
詳細
|
(2R,5R)-2,5-Diphenylpyrrolidine |
(2R,5R)-2,5-二苯基吡咯烷 |
155155-73-0 |
詳細
|
2-Hydroxy-1,4-benzoquinone |
2-羥基對苯醌 |
2474-72-8 |
詳細
|
Memantine USP RC E |
N-甲?;?3,5-二甲基金剛烷 |
351329-88-9 |
詳細
|
beta-Aspartyl-Aspartic Acid |
門冬氨酸鳥氨酸雜質(zhì) |
60079-22-3 |
詳細
|
N-Boc Linagliptin |
叔丁氧羰基-利拉利汀 |
668273-75-4 |
詳細
|
Linezolid N-Oxide |
利奈唑胺雜質(zhì) 3 |
189038-36-6 |
詳細
|
Medroxyprogesterone Acetate EP Impurity I |
MEDROXYPROGESTERONE ACETATE EP IMPURITY I |
|
詳細
|
(S)-Levetiracetam EP Impurity A |
(2S)-2-(2-氧代吡咯烷-1-基)丁酸 |
102849-49-0 |
詳細
|
Levosimendan Dimer |
左旋西孟旦雜質(zhì)3 |
618458-79-0 |
詳細
|
Levetiracetam EP Impurity A |
alpha-乙基-2-氧代-1-吡咯烷乙酸 |
67118-31-4 |
詳細
|
Dexmedetomidine |
右美托咪定 |
113775-47-6 |
詳細
|
Imatinib EP impurity C |
N-去甲基伊馬替尼 |
404844-02-6 |
詳細
|
(3b,5b,15a,16a)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one |
(3b,5b,15a,16a)-15,16-二氫-3,5-二羥基-3'H-環(huán)丙并[15,16]雄甾-6,15-二烯-17-酮 |
82543-15-5 |
詳細
|
Latanoprost Acid |
拉坦前列腺素(游離酸) |
41639-83-2 |
詳細
|
(R)-Licarbazepine Acetate |
醋酸奧曲肽雜質(zhì) |
186694-45-1 |
詳細
|
Lidocaine Dichloro Impurity |
丙胺卡因雜質(zhì)A |
39084-88-3 |
詳細
|
2-Chloro-1-(p-tolyl)ethanone |
對甲基-2-氯乙酰苯 |
4209-24-9 |
詳細
|
Isothipendyl Impurity 1 HCl |
10H-Pyrido[3,2-b][1,4]benzothiazine-10-ethanamine, N,N,β-trimethyl-, hydrochloride (1:1) |
132962-42-6 |
詳細
|
Latanoprost Lactone Diol |
拉坦前列腺素內(nèi)酯二醇 |
145667-75-0 |
詳細
|
6α-Methylprednisolone 21-Hemisuccinate Sodium Salt |
甲基潑尼松龍琥珀酸鈉 |
2375-03-3 |
詳細
|
(R)-Ketorolac |
(1R)-5-苯基-2,3-二氫-1H-吡啶-1-羧酸 |
66635-93-6 |
詳細
|
(15S)-Latanoprost |
15(S)-拉坦前列素 |
145773-22-4 |
詳細
|
Methyl4-bromo-6-chloronicotinate |
4-溴-6-氯煙酸甲酯 |
1256790-93-8 |
詳細
|
Loxoprofen Ring-opening Impurity |
氯索洛芬開環(huán)雜質(zhì) |
1091621-61-2 |
詳細
|
Lidocaine EP Impurity D HCl |
去乙基利多卡因 |
7729-94-4 |
詳細
|
15-Keto Latanoprost |
15-酮拉坦前列素 |
135646-98-9 |
詳細
|
N-Benzyl Vinyl Analog Medetomidine |
美托咪定標準品018 |
2250243-56-0 |
詳細
|
Imatinib EP Impurity D Chloride |
伊馬替尼雜質(zhì)72 |
1821122-73-9 |
詳細
|
Imatinib EP impurity J |
伊馬替尼(哌啶)-N-氧化物 |
571186-91-9 |
詳細
|
(S)-Ketorolac |
(1S)-5-苯基-2,3-二氫-1H-吡啶-1-羧酸 |
66635-92-5 |
詳細
|
Lisinopril EP Impurity F |
賴諾普利雜質(zhì)F |
1132650-67-9 |
詳細
|
Methylprednisolone EP Impurity L |
氟甲松龍相關(guān)物質(zhì)A |
6870-94-6 |
詳細
|
Lidocaine EP Impurity G HCl |
N-(2,6-二甲基苯基)-2-[(1-甲基乙基)氨基]乙酰胺鹽酸鹽 |
35891-87-3 |
詳細
|
Methylprednisolone EP Impurity J |
甲基潑尼松龍醋酸酯 |
53-36-1 |
詳細
|
Ibrutinib Addition Adduct |
依魯替尼雜質(zhì)6 |
1987905-93-0 |
詳細
|
Linagliptin N-Acetyl Impurity |
利格列汀N-乙酰雜質(zhì) |
1803079-49-3 |
詳細
|
Latanoprost EP Impurity D |
NUSCAFULQNHZJJ-UHFFFAOYSA-N |
2088449-88-9 |
詳細
|
3,4,5-Tris(benzyloxy)benzyl Alcohol |
3,4,5-三芐氧基苯甲醇 |
79831-88-2 |
詳細
|
Imatinib EP Impurity B |
N-(3-胍基-4-甲基亞苯基)-4-(甲基哌嗪-1-基-甲基)苯甲酰胺 |
581076-65-5 |
詳細
|
Isononylphenol |
異壬基苯酚 |
11066-49-2 |
詳細
|
Exodiene Lurasidone |
魯拉西酮雜 |
3024924-65-7 |
詳細
|
Lidocaine EP Impurity K HCl |
利多卡因雜質(zhì)K |
50295-20-0 |
詳細
|
Lansoprazole Thioxo Impurity |
蘭索拉唑硫醇雜質(zhì) |
1246819-06-6 |
詳細
|
Ethyl 4-bromo-1-methyl-1H-imidazole-2-carboxylate |
4-溴-1-甲基-1H-咪唑-2-羧酸乙酯 |
1260672-33-0 |
詳細
|
Lidocaine EP Impurity I HCl |
2-(二乙氨基)-N-(2,4-二甲基苯基)乙酰胺鹽酸鹽 |
17289-54-2 |
詳細
|
(S)-Linagliptin |
利拉利汀雜質(zhì)G |
668270-11-9 |
詳細
|
6-alfa-Methylcortisone |
甲潑尼龍雜質(zhì) |
1746-38-9 |
詳細
|
Hydralazine Triazolo Methyl Impurity |
肼屈嗪三唑甲基雜質(zhì) |
20062-41-3 |
詳細
|
Cyclo(-Ala-Gln) |
環(huán)-(L-丙氨酰-L-谷氨酰胺) |
268221-76-7 |
詳細
|
Lacosamide EP Impurity B |
(R)-O-乙酰基-拉克酰胺 |
1318777-54-6 |
詳細
|
Mesalamine EP Impurity P |
美沙拉嗪EP雜質(zhì)P |
887256-40-8 |
詳細
|
Hydrocortisone EP Impurity M |
11-表氫化可的松 |
566-35-8 |
詳細
|
Lercanidipine Acid |
Lercanidipine Impurity K |
855592-30-2 |
詳細
|
Mesalazine EP Impurity J DiHCl |
美沙拉明EP雜質(zhì)J |
2514682-10-9 |
詳細
|
2-Propenylpropylpropanedioic Acid Diethyl Ester |
2-Propenylpropylpropanedioic Acid Diethyl Ester |
59726-38-4 |
詳細
|
Levomedetomidine HCl |
鹽酸左美托咪定 |
190000-46-5 |
詳細
|
Lidocaine EP Impurity F HCl |
2-(二乙氨基)-N-(2,3-二甲基苯基)乙酰胺鹽酸鹽 |
857170-72-0 |
詳細
|
ent-Lurasidone |
魯拉西酮雜質(zhì)3 |
1448443-35-3 |
詳細
|
6α-Methylprednisolone 21-Hemisuccinate |
甲基潑尼松龍琥珀酸酯 |
2921-57-5 |
詳細
|
N-Desmethyl Ibandronate |
伊班膦酸鈉雜質(zhì)3 |
905808-25-5 |
詳細
|
(S)-Licarbazepine |
(S)-10-羥基二氫-5H-二苯并[B,F]氮雜卓-5-甲酰胺 |
104746-04-5 |
詳細
|
N-Methyl-N’-nitrosopiperazine |
1-甲基-4-亞硝基哌嗪 |
16339-07-4 |
詳細
|
Ibrutinib N-Oxide |
依魯替尼雜質(zhì)31 |
2417548-74-2 |
詳細
|
Linagliptin Impurity 31 |
7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3S)-3-piperidinylamino]-1H-purine-2,6-dione |
2253964-85-9 |
詳細
|
Ibrutinib Diamide Impurity |
依魯替尼雜質(zhì)2 |
2031255-27-1 |
詳細
|
Lurasidone Aminomethyl Impurity DiHCl |
N-[1R,2R-(2-Methylamino)cyclohex-1-yl)methyl]-N’-(1,2-benzisothiazol-3-yl)piperazine Dihydrochloride |
1260025-93-1 |
詳細
|
2,4-Diamino-5,6-dichloropyrimidine 3-oxide |
5,6-二氯-2,4-嘧啶二胺 3-氧化物 |
35139-68-5 |
詳細
|
Indapamide EP Impurity B |
脫氫吲達帕胺 |
63968-75-2 |
詳細
|
1,3-Dibromo-5-(tert-butyl)-2-nitrobenzene |
2,6-二溴-4-叔丁基-硝基苯 |
2828612-34-4 |
詳細
|
(6S)-5,6-Dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-one 7,7-dioxide |
多佐胺-2-3 |
148719-91-9 |
詳細
|
(2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate and (2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 4-hydroxybenzoate |
(2R,3R,4R,5S)-2,3,4,5,6-五羥基己基4-羥基苯甲酸酯 |
334948-52-6 |
詳細
|
2,4-Diamino-5-chloro-6-piperidine pyrimidine-3-oxide |
米諾地爾雜質(zhì)18 |
2889432-05-5 |
詳細
|